This book has discussed the way pharmaceuticals can produce sex/gender and be sexed/gendered in many different contexts. It presents empirical cases, covering pharmaceuticals on both ends of the adult subject and sex/gender in many different contexts. As such, it is an attempt to show the productive benefits of applying feminist technoscience studies’ theoretical tools about material-discursive entanglements and subjectivity to pharmaceutical studies and the political traction this can produce.